HOXB13 and prostate cancer: Our ability to impute the HOXB13 G84E mutation and calculate the age-specific risk of prostate cancer for carriers, along with evidence for association with a number of other cancers, highlights the value of combining sequence data with a large cohort of genotyped individuals to assess the impact of rare variants on multiple diseases.